Changes in liver function induced by flutamide in patients with prostate cancer (Studies in patients treated with total androgen blockage)

Japanese Journal of Urology

Volumn 91, Issue 6, 2000, Pages 556-561

  Ikemoto, Isao ^a   Ohishi, Yukihiko ^a   Yamazaki, Haruki ^a   Wada, Tetsuro ^a   Aizawa, Yoshio ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Flutamide; Liver toxicity; Prostate cancer

Indexed keywords

FLUTAMIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; HUMAN; LIVER FUNCTION; LIVER TOXICITY; MALE; PROSTATE CANCER;

EID: 0033926048     PISSN: 00215287     EISSN: None     Source Type: Journal    
DOI: 10.5980/jpnjurol1989.91.556     Document Type: Article

References (10)

1. Gomez, J., Dupont, A., Cusan, L,. Tremblay, M., Suburu, R., Lemay, M. and Labrie, F. : Incidence of liver toxicity associated with the use of flutamide in prostatic cancer patients. J. Med., 92, 465-470, 1992
2. Akaza, H., Isaka, S., Usami, M., Kanetake, H., Kotake, T., Kolso, K. and Aso. Y. : Recommended dose of flutamide with LHRH agonist therapy in patients with advanced prostatic cancer. Int.J. Urol., 3, 468-471, 1996.
3. The Liver, p 882-922, 1987.